PMDIY (Pro Medicus) Short-term investments

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PMDIY Pro Medicus Ltd PMDIY
73 GF Score
Price $23.45
GF Value $35.74
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Pro Medicus Short-term investments?

Short-term investments only applies to insurance companies.

PMDIY
73GF Score
Pro Medicus Ltd PMDIY
Short-term investments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Pro Medicus (PMDIY) Overvalued in 2026?

Based on GuruFocus' analysis, Pro Medicus stock appears to be undervalued. The current stock price of $23.45 is trading 34.4% below its estimated GF Value™ of $35.74. GuruFocus considers Pro Medicus to be Possible Value Trap.

Key valuation signals for PMDIY:

  • Short-term investments:
  • GF Value™: $35.74 vs. price of $23.45 (34.4% below fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the PMDIY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pro Medicus Business Description

Address 450 Swan Street, Richmond, VIC, AUS, 3121
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2025, Pro Medicus earned 90% of revenue in North America, 8% from Australia, and the remaining 2% in Europe.
73GF Score

Get the complete analysis for PMDIY

Short-term investments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$23.45
Price
$35.74
GF Value